PMID: 16510046Mar 3, 2006Paper

Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation

Current Atherosclerosis Reports
Amandeep Dhaliwal, Vinay Thohan

Abstract

Over the past 40 years, cardiac transplantation has evolved as the single best long-term option for eligible candidates with end-stage heart failure. Approximately 2000 transplants are performed annually in the United States, and with the institution of calcineurin-based immunotherapy, surveillance biopsies, and programmatic-based patient care, life expectancy at 1 and 12 years is 85% and 50%, respectively. Cardiac allograft vasculopathy (CAV) is the number one cause of death after the first year of transplantation. The incidence of CAV remains as high as 50% at 5 years, with life expectancy significantly abbreviated once it is recognized. Although current immunotherapy has reduced the likelihood of cellular rejection, it has not impacted CAV substantially. Better treatment of established risk factors and the advent of newer antiproliferative immunotherapy may hold promise in treating CAV. However, future therapies must address the multitude of mechanisms underlying CAV. This manuscript reviews the pathophysiology, clinical manifestations, screening, and diagnostic strategies for cardiac allograft vasculopathy while emphasizing current treatment paradigms designed to stave off or retard the progression of CAV.

References

Jun 23, 1989·JAMA : the Journal of the American Medical Association·M T GrattanN E Shumway
Dec 4, 1987·JAMA : the Journal of the American Medical Association·J S Schroeder, S Hunt
May 1, 1970·Circulation·C P BieberJ Kosek
Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Jul 1, 1995·Journal of the American College of Cardiology·A A HalleT R Aversano
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·C ShiE Haber
Sep 1, 1996·Journal of the American College of Cardiology·S Z GaoE B Stinson
Aug 1, 1996·Coronary Artery Disease·R H MohiaddinM H Yacoub
Oct 27, 1997·JAMA : the Journal of the American Medical Association·C A LabarrereW P Faulk
Nov 12, 1998·The American Journal of Pathology·A Räisänen-SokolowskiM E Russell
Feb 18, 1999·The Journal of Clinical Investigation·C ShiE Haber
Jul 10, 1999·Journal of the American College of Cardiology·K PethigA Haverich
Nov 24, 1999·The American Journal of Cardiology·L GullestadP Aukrust
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·H DietrichQ Xu
Jun 27, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·C M Ballantyne
Jun 27, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·A KeoghJ Mundy
Jul 25, 2000·JAMA : the Journal of the American Medical Association·C A LabarrereH Halbrook
Nov 15, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·A IwataM D Allen
Dec 8, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·E Bosimini
Jan 11, 2001·Zeitschrift für Kardiologie·M L Rose

❮ Previous
Next ❯

Citations

Oct 9, 2007·Antioxidants & Redox Signaling·Robert OllingerFritz H Bach
Aug 23, 2008·Annual Review of Pathology·Richard N Mitchell
Aug 6, 2014·Proceedings of the National Academy of Sciences of the United States of America·Bara SarrajM Javeed Ansari
Dec 17, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Jun-ichi SuzukiRyozo Nagai
Apr 15, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·María J AcevedoAntonio Núñez-Roldán
Jul 10, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Dilip S NathThalachallour Mohanakumar
Feb 13, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Heather RossUNKNOWN CADENCE Study Group
Oct 8, 2013·Nitric Oxide : Biology and Chemistry·Jing LeiTimothy R Billiar
Oct 30, 2016·Transplantation Proceedings·J M AliJ Parmar
Jan 14, 2021·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Calum HoneymanHenk Giele

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Susan StewartMargaret E Billingham
Springer Seminars in Immunopathology
Paul J MichaelsRobert B Colvin
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Elaine F ReedInternational Society for Heart and Lung Transplantation
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Abdallah G Kfoury, M Elizabeth H Hammond
© 2021 Meta ULC. All rights reserved